Xvivo Perfusion AB (XVIPF)
22.81
0.00 (0.00%)
USD |
OTCM |
May 15, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 718.53M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -30.67% |
| Valuation | |
| PE Ratio | 90.48 |
| PE Ratio (Forward) | |
| PS Ratio | 8.113 |
| Price to Book Value | 3.155 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.0566 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 78.31% |
Profile
| Xvivo Perfusion AB is a medical technology company operates in the field of organ transplantation technology. It involves in developing and marketing solutions and systems for assessing the usability of organs, and maintaining organs in good condition outside the body pending transplantation. Its products include XPS, XPS Disposable Kit, Steen Solution, Organ Chamber, Lung Cannula Set, Perfadex and Silicone Tubing Set. The company operates through the following segments: Thoracic, Abdominal and Services. The Thoracic segment engages in the sale of products for lung and heart transplantation. The Abdominal segment engages in the sale of products for liver and kidney transplantation. The Services segment engages in providing organ recovery-related services. The company was founded by Magnus Nilsson on December 17, 1998 and is headquartered in Gothenburg, Sweden. |
| URL | http://www.xvivogroup.com |
| Investor Relations URL | N/A |
| HQ State/Province | Vastra Gotaland |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Jul. 14, 2026 (est.) |
| Last Earnings Release | Apr. 24, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Xvivo Perfusion AB is a medical technology company operates in the field of organ transplantation technology. It involves in developing and marketing solutions and systems for assessing the usability of organs, and maintaining organs in good condition outside the body pending transplantation. Its products include XPS, XPS Disposable Kit, Steen Solution, Organ Chamber, Lung Cannula Set, Perfadex and Silicone Tubing Set. The company operates through the following segments: Thoracic, Abdominal and Services. The Thoracic segment engages in the sale of products for lung and heart transplantation. The Abdominal segment engages in the sale of products for liver and kidney transplantation. The Services segment engages in providing organ recovery-related services. The company was founded by Magnus Nilsson on December 17, 1998 and is headquartered in Gothenburg, Sweden. |
| URL | http://www.xvivogroup.com |
| Investor Relations URL | N/A |
| HQ State/Province | Vastra Gotaland |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Jul. 14, 2026 (est.) |
| Last Earnings Release | Apr. 24, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |